Cell Signaling Technology

IL-13RA2/CD213a2 (E7U7B) Rabbit Monoclonal Antibody

#85677 · $168

4
Citing papers
54
Combined citations
Supplier page Find this product

Research areas

CAR-T cell therapy research3Vascular Tumors and Angiosarcomas2Cutaneous lymphoproliferative disorders research2Hair Growth and Disorders1Virus-based gene therapy research1Wound Healing and Treatments1CRISPR and Genetic Engineering1Dermatologic Treatments and Research1

Papers citing this product

1
IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation
JCI Insight·2023·52 cit.·DOI
2
IL-13/IL-13Rα2 axis promotes proliferation of angiosarcoma cells
Scientific Reports·2025·1 cit.·DOI
3
Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial
Nature Communications·2026·1 cit.·DOI
4
IL-13/IL-13Rα2 axis promotes proliferation of angiosarcoma cells
bioRxiv (Cold Spring Harbor Laboratory)·2024·DOI

Similar products

ProductVendorPricePapers
IL-13RA2/CD213a2 (E7U7B) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$865200
IL-13RA2/CD213a2 (E7U7B) Rabbit Monoclonal Antibody — Evidence — PubIndex